scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
scPharmaceuticals (NASDAQ: SCPH), a pharmaceutical company focused on cardiorenal healthcare innovations, has scheduled its Q2 2025 financial results announcement for August 7, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the quarterly results and provide business updates.
Interested participants can join via phone using the toll-free number (800) 715-9871 or toll number (646) 307-1963 with passcode 4965353. The webcast will be available through the company's Investor Relations section on their website.
scPharmaceuticals (NASDAQ: SCPH), un'azienda farmaceutica specializzata in innovazioni per la salute cardiorenale, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 7 agosto 2025, dopo la chiusura del mercato. La società terrà una conference call e una webcast alle 16:30 ET per discutere i risultati trimestrali e fornire aggiornamenti aziendali.
Gli interessati potranno partecipare telefonicamente chiamando il numero verde (800) 715-9871 o il numero a pagamento (646) 307-1963 con il codice di accesso 4965353. La webcast sarà disponibile nella sezione Relazioni con gli Investitori sul sito web della società.
scPharmaceuticals (NASDAQ: SCPH), una compañía farmacéutica centrada en innovaciones en salud cardiorrenal, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el 7 de agosto de 2025, después del cierre del mercado. La empresa realizará una llamada en conferencia y una transmisión en vivo a las 4:30 p.m. ET para discutir los resultados trimestrales y proporcionar actualizaciones comerciales.
Los interesados pueden unirse por teléfono usando el número gratuito (800) 715-9871 o el número de pago (646) 307-1963 con el código de acceso 4965353. La transmisión estará disponible en la sección de Relaciones con Inversionistas en el sitio web de la compañía.
scPharmaceuticals (NASDAQ: SCPH)는 심장신장 건강 혁신에 중점을 둔 제약 회사로, 2025년 2분기 재무 실적 발표를 2025년 8월 7일 장 마감 후에 예정하고 있습니다. 회사는 분기 실적과 사업 업데이트를 논의하기 위해 동부시간 오후 4시 30분에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
참가를 원하는 분들은 무료 전화번호 (800) 715-9871 또는 유료 전화번호 (646) 307-1963에 접속 코드 4965353을 입력하여 전화로 참여할 수 있습니다. 웹캐스트는 회사 웹사이트의 투자자 관계 섹션에서 시청할 수 있습니다.
scPharmaceuticals (NASDAQ : SCPH), une société pharmaceutique spécialisée dans les innovations en santé cardiorénale, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le 7 août 2025, après la clôture du marché. La société organisera une conférence téléphonique et une webdiffusion à 16h30 ET pour discuter des résultats trimestriels et fournir des mises à jour sur ses activités.
Les participants intéressés peuvent se joindre par téléphone en utilisant le numéro gratuit (800) 715-9871 ou le numéro payant (646) 307-1963 avec le code d'accès 4965353. La webdiffusion sera disponible dans la section Relations Investisseurs du site web de la société.
scPharmaceuticals (NASDAQ: SCPH), ein Pharmaunternehmen, das sich auf Innovationen im Bereich der kardiorenalen Gesundheit spezialisiert hat, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 7. August 2025 nach Börsenschluss angesetzt. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Quartalsergebnisse zu besprechen und Geschäftsaktualisierungen zu geben.
Interessierte können telefonisch über die gebührenfreie Nummer (800) 715-9871 oder die gebührenpflichtige Nummer (646) 307-1963 mit dem Zugangscode 4965353 teilnehmen. Der Webcast wird über den Investor-Relations-Bereich auf der Website des Unternehmens verfügbar sein.
- None.
- None.
Management to host conference call and webcast, after-market on August 7, 2025, at 4:30 p.m. ET
BURLINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Thursday, August 7, 2025, to discuss the financial results for the second quarter 2025 and provide a business update.
A link to the live webcast can be found here.
Participants should dial (800) 715-9871 (toll-free) or (646) 307-1963 (toll) and use the passcode 4965353
The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., (781) 301-6869
kmiranda@scpharma.com
Investors:
Matthew Beck
astr partners, (917) 415-1750
matthew.beck@astrpartners.com
FAQ
When will scPharmaceuticals (SCPH) release Q2 2025 earnings?
How can I join the scPharmaceuticals Q2 2025 earnings call?
What time is the SCPH Q2 2025 earnings conference call?
Where can I access the replay of SCPH's Q2 2025 earnings call?
